This prospective, single-center, observational feasibility and safety study will evaluate the use of the GelPOINT® Path transanal access platform during endoscopic submucosal dissection (ESD) for the removal of colorectal polyps. The GelPOINT® Path system is designed to improve access, maintain stable insufflation, and enhance visualization during advanced endoscopic procedures.
The study will enroll adult patients undergoing ESD for eligible colorectal lesions. The primary objective is to evaluate the technical feasibility, procedural performance, and safety of GelPOINT® Path-assisted ESD. Procedural outcomes, including procedure speed, technical success, resection outcomes, and procedure-related adverse events, will be collected prospectively. Participants will receive standard clinical care and will be followed for approximately 4 weeks after the procedure to assess delayed adverse events.
Inclusion Criteria:
Exclusion Criteria:
Tara.Keihanian@bcm.edu631-800-4142
Adult participants undergoing endoscopic submucosal dissection (ESD) for eligible colorectal polyps using the GelPOINT® Path transanal access platform as part of standard clinical care. The study will prospectively evaluate the feasibility, technical performance, and safety of GelPOINT® Path-assisted ESD, including procedural outcomes and procedure-related adverse events.
Prospective Study of a New Endolumenal Device Used During Endoscopic Polypectomy in the Colon
A Double Balloon Endoscopic Platform for ESD
PARADIGM - En Bloc Trial With the EndoQuest Endoluminal Surgical (ELS) System
Hybrid Versus Non-Hybrid Endoscopic Submucosal Dissection for Colorectal Polyps (SHORT-ESD)
Comparison Rectal Endoscopic Submucosal Dissection to Endoscopic Mucosal Resection
Endocuff Vision Assisted vs. Standard Polyp Resection in the Colorectum
A Technique Using EBL for Removal of Pedunculated Colon Polyps
Effectiveness and Safety of the Endoscopic Removal of Large and Flat Colonic Polyps With LumenR RetractorTM